Raju Saka

453 total citations
10 papers, 340 citations indexed

About

Raju Saka is a scholar working on Molecular Biology, Surgery and Pharmaceutical Science. According to data from OpenAlex, Raju Saka has authored 10 papers receiving a total of 340 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 2 papers in Surgery and 2 papers in Pharmaceutical Science. Recurrent topics in Raju Saka's work include RNA Interference and Gene Delivery (3 papers), Nanoparticle-Based Drug Delivery (2 papers) and Retinoids in leukemia and cellular processes (2 papers). Raju Saka is often cited by papers focused on RNA Interference and Gene Delivery (3 papers), Nanoparticle-Based Drug Delivery (2 papers) and Retinoids in leukemia and cellular processes (2 papers). Raju Saka collaborates with scholars based in India, Israel and United States. Raju Saka's co-authors include Wahid Khan, Naveen Chella, Nagavendra Kommineni, Abraham J. Domb, Kaisar Raza, Sneha Rathi, Harsha Jain, Upendra Bulbake, Pavimol Angsantikul and Anjali Jain and has published in prestigious journals such as Pharmaceutical Research, Environmental Chemistry Letters and Chemistry and Physics of Lipids.

In The Last Decade

Raju Saka

10 papers receiving 339 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Raju Saka 125 93 90 67 51 10 340
Mariam Zewail 222 1.8× 131 1.4× 103 1.1× 80 1.2× 67 1.3× 32 576
Joana A.D. Sequeira 170 1.4× 163 1.8× 60 0.7× 48 0.7× 54 1.1× 10 505
Kai Dong 105 0.8× 176 1.9× 77 0.9× 36 0.5× 10 0.2× 32 527
Heba F. Mansour 238 1.9× 70 0.8× 47 0.5× 30 0.4× 37 0.7× 20 426
Xun Feng 89 0.7× 72 0.8× 70 0.8× 30 0.4× 47 0.9× 11 319
Ziting Cheng 81 0.6× 108 1.2× 117 1.3× 57 0.9× 30 0.6× 9 365
Hend Abd-Allah 106 0.8× 46 0.5× 55 0.6× 12 0.2× 42 0.8× 26 321
Young Joon Park 150 1.2× 88 0.9× 31 0.3× 47 0.7× 94 1.8× 24 412
Salwa 126 1.0× 132 1.4× 55 0.6× 22 0.3× 25 0.5× 26 380

Countries citing papers authored by Raju Saka

Since Specialization
Citations

This map shows the geographic impact of Raju Saka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Raju Saka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Raju Saka more than expected).

Fields of papers citing papers by Raju Saka

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Raju Saka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Raju Saka. The network helps show where Raju Saka may publish in the future.

Co-authorship network of co-authors of Raju Saka

This figure shows the co-authorship network connecting the top 25 collaborators of Raju Saka. A scholar is included among the top collaborators of Raju Saka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Raju Saka. Raju Saka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Kommineni, Nagavendra, et al.. (2022). Stealth Liposomal Chemotherapeutic Agent for Triple Negative Breast Cancer with Improved Pharmacokinetics. Nanotheranostics. 6(4). 424–435. 10 indexed citations
2.
Kommineni, Nagavendra, Vaskuri G. S. Sainaga Jyothi, Arun Butreddy, et al.. (2022). SNAC for Enhanced Oral Bioavailability: An Updated Review. Pharmaceutical Research. 40(3). 633–650. 20 indexed citations
3.
Saka, Raju, Naveen Chella, & Wahid Khan. (2021). Development of Imatinib Mesylate-Loaded Liposomes for Nose to Brain Delivery: In Vitro and In Vivo Evaluation. AAPS PharmSciTech. 22(5). 192–192. 33 indexed citations
4.
Saka, Raju, Harsha Jain, Nagavendra Kommineni, Naveen Chella, & Wahid Khan. (2020). Enhanced penetration and improved therapeutic efficacy of bexarotene via topical liposomal gel in imiquimod induced psoriatic plaque model in BALB/c mice. Journal of Drug Delivery Science and Technology. 58. 101691–101691. 47 indexed citations
5.
Saka, Raju & Naveen Chella. (2020). Nanotechnology for delivery of natural therapeutic substances: a review. Environmental Chemistry Letters. 19(2). 1097–1106. 52 indexed citations
6.
Saka, Raju, et al.. (2019). Dithranol-loaded nanostructured lipid carrier-based gel ameliorate psoriasis in imiquimod-induced mice psoriatic plaque model. Drug Development and Industrial Pharmacy. 45(5). 826–838. 72 indexed citations
7.
Kommineni, Nagavendra, Raju Saka, Upendra Bulbake, & Wahid Khan. (2018). Cabazitaxel and thymoquinone co-loaded lipospheres as a synergistic combination for breast cancer. Chemistry and Physics of Lipids. 224. 104707–104707. 33 indexed citations
8.
Rathi, Sneha, Raju Saka, Abraham J. Domb, & Wahid Khan. (2018). Protein‐based bioadhesives and bioglues. Polymers for Advanced Technologies. 30(2). 217–234. 41 indexed citations
9.
Kommineni, Nagavendra, Raju Saka, Wahid Khan, & Abraham J. Domb. (2017). Non-polymer drug-eluting coronary stents. Drug Delivery and Translational Research. 8(4). 903–917. 19 indexed citations
10.
Jain, Anjali, et al.. (2017). Therapeutic Approaches for the Delivery ofTNF-αsiRNA. Therapeutic Delivery. 8(5). 343–355. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026